Category | Guidelines on diabetes, pre-diabetes and cardiovascular diseases [4] | Guidelines for the management of chronic coronary syndromes [7] | Guidelines for the management of dyslipidaemias in collaboration with the EAS [8] |
---|---|---|---|
Very high risk | Concomitant established cardiovascular disease | Â | Target organ damagec |
Other target organ damagea |  | ≥ 3 major risk factors | |
≥ 3 major risk factorsb |  | Early onset T1DM for > 20 years | |
Early onset T1DM for > 20 years |  |  | |
High risk | Diabetes ≥ 10 years without target organ damage and an additional risk factor | Diffuse multivessel CAD | Diabetes ≥ 10 years without target organ damage and an additional risk factor |
Moderate risk | Young patientsd with diabetes for < 10 years without an additional risk factor | Any of recurrent MI, PAD, HF, or CKD with eGFR 15–59 mL/min/1.73 m2 | Young patientsd with diabetes for < 10 years without an additional risk factor |